Ahead of Suominen's Q1 report, we lower 2026E-27E comparable EBITDA by 16-28% owing to increasing ra...
Ahead of Xplora's Q1 report, we decrease our 2026-28 EBITDA estimates by 4-6%, owing to slightly low...
Redeye makes three model changes ahead of Catella's Q1 2026 results (8 May), leaving its investment ...
Duell announced today that it is taking further actions to improve NWC management.
Coor rapporterade ett starkt Q1-resultat som överträffade förväntningarna, drivet av hög lönsamhet i...
Investeringsportföljen minskade till 486,3 MUSD (-23,8% årsbasis) främst p.
Redeye retains its positive view of Carasent following the acquisition of Infosolutions.
Last week, NAGA reported preliminary Q1 figures that came in as a mixed bag with softer than expecte...
Net sales from continuing operations was in line with our expectation in Q1.
InvesteraMera ger en kommentar på Q1-rapporten från Hansa Biopharma.
GFT will report Q1 26 results on May 7. The results should underpin continued improvement in momentu...
On Friday, ATOSS released strong Q1 results that confirmed the company's ability to compound top-lin...
Consti will report its Q1 results on 29th of April.
The report supported our take on increasing thoracic sales and showed continued FCF improvements (Q4...
Reported growth is set to be very strong for Q1, due to the acquisition of Lacon Group.
AVTECH's Q1 2026 results confirmed pre-announced figures, with net sales of SEK11.
Tagmaster is showing continued progress in Q1 with good top-line growth, double digit EBITDA margins...
Redeye has updated its forecasts and valuation following Modelon’s Q1 2026 report, which came in bel...
* Soft sales mostly on FX and order timing * We cut '26e-'27e adj.
* Muted sales more than offset by margin expansion * Limited estimate changes on market uncertaintie...
